Clinical Trials

146 enrolled

Muscle Invasive Bladder Cancer (MIBC)

NCT06114940 2026-03-05

PLUTO

Phase 2 Terminated

17 enrolled

Carcinoma, Renal Cell

NCT04553939 2026-01-02

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Phase 2 Completed

50 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07314723 2026-01-02

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

90 enrolled

Phase 2 Active not recruiting

Carcinoma, Transitional Cell

NCT06584435 2025-12-19

TUORA

100 enrolled

High-risk Renal Cell Carcinoma

NCT07279597 2025-12-19

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

45 enrolled

Phase 2 Active not recruiting

Muscle-invasive Bladder Urothelial Carcinoma

NCT05975307 2025-12-01

BCIRT-01

71 enrolled

Urinary Bladder Neoplasms

NCT07201675 2025-10-01

Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment

59 enrolled

Muscle Invasive Bladder Cancer (MIBC)

NCT07189793 2025-09-24

OHAI-NMIBC-01

106 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT07172386 2025-09-16

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT07047001 2025-07-09

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

60 enrolled

Carcinoma, Renal Cell

NCT06415318 2025-04-22

TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer

25 enrolled

Penile Neoplasms

NCT06823427 2025-03-21

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

60 enrolled

Carcinoma, Transitional Cell

NCT04861584 2024-12-04

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

41 enrolled

Urinary Bladder Neoplasms

NCT06690697 2024-11-15

Combination of Toripalimab and JS004 Therapy for ccRCC

80 enrolled

Carcinoma, Renal Cell

NCT05979740 2023-08-31

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

6 enrolled

Muscle Invasive Bladder Cancer

NCT04099589 2022-03-29

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

64 enrolled

Upper Tract Urinary Carcinoma

NCT04211012 2020-11-13

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

30 enrolled

Carcinoma, Transitional Cell

NCT04385654 2020-05-13

Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma

40 enrolled